Further investigations have revealed that activated ErbB2 stimulates the expression of GLS in cancer cells through the PI3K/Akt-independent nuclear factor-kappa B (NF-kB) pathway in breast and gastric cancer [103, 104]. The gene discussed is ERBB2; the disease is cancer.